Data + Perspectives: Clinical Investigators Explore the Emerging Role of PARP Inhibition in the Management of Breast Cancer

Addressing Current Questions and Controversies in the Management of Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Waldenström Macroglobulinemia and Amyloidosis

A 2-Part Friday Satellite Symposia Series Preceding the 59th ASH Annual Meeting

The 15th Annual Winter Lung Cancer Conference